Condition: Acute Decompensated Heart Failure · Sponsor: Nephronyx LTD
The objective of this interventional study is to evaluate the safety and functional performance of the Nephronyx System in patients with ADHF, presenting clinical signs of volume overload and compromised response to diuretics.
This description comes directly from the study's public registry record.
Sagy Karavany · 972-8-9999734 · sagy@nephronyx.com
Always discuss trial participation with your own doctor first.
| Rambam Medical Center | Haifa, Israel | Recruiting |
| Shaare Zedek Medical Center | Jerusalem, Israel | Recruiting |
| The Baruch Padeh Medical Center, Poriya | Poria Illit, Israel | Recruiting |
| Kaplan Medical Center | Rehovot, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05759806